The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles implications for individualization of therapy
Abstract
BACKGROUND: Serum concentrations of anti-Müllerian hormone (AMH) correlate with oocyte yield in assisted reproduction treatment (ART) cycles, however, performance of AMH for prediction of live birth is unknown. METHODS: A total of 340 first cycle IVF/ICSI patients (median age 34.0 years, inter-quartile range 31.0-37.0 years), had basal plasma AMH and FSH measured and their predictive values for live birth and oocyte yield compared. RESULTS: AMH predicts live birth [contribution to variance (CTV) 3.84%, P < 0.001] and oocyte yield (r = 0.71, P < 0.0001, CTV 7.3%, P < 0.0001). Compared with age and FSH, AMH performs better in prediction of live births [area under receiver operating characteristic curve (AUC) 0.62, 95% CI 0.55-0.68; FSH AUC 0.42, 95% CI 0.35-0.49; age AUC 0.48, 95% CI 0.41-0.55, P = 0.0028] and excessive response to ovarian stimulation (AMH AUC 0.90, 95% CI 0.83-0.96; FSH AUC 0.32, 95% CI 0.23-0.40; age AUC 0.57, 95% CI 0.43-0.71, P < 0.001). AMH prediction of oocyte yield is independent of age (r = -0.28, P < 0.0001, CTV 1.4%, P = 0.006), however, a significant negative interaction (CTV 3.6%, P < 0.0001) exists. AMH demonstrates improved differential distributions for non-, poor, normal and excessive ovarian responses relative to FSH and age. CONCLUSIONS: Plasma AMH is a superior predictor of live birth and anticipated oocyte yield compared with FSH and age, facilitating individualization of therapy prior to first ART cycle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Weenen, C. (2004) · Molecular Human Reproduction · doi:10.1093/molehr/gah015 · Cited by 1,285
A systematic review of tests predicting ovarian reserve and IVF outcome
Broekmans, F. J., Kwee, J., Hendriks, D. J., Mol, B. W., & Lambalk, C. B. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml034 · Cited by 1,258
Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve
van Rooij, I. A. J. (2002) · Human Reproduction · doi:10.1093/humrep/17.12.3065 · Cited by 951
Antimüllerian hormone serum levels: a putative marker for ovarian aging
de Vet, A., Laven, J. S. E., de Jong, F. H., Themmen, A. P. N., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02993-4 · Cited by 887
Anti-Mullerian Hormone Inhibits Initiation of Primordial Follicle Growth in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Ingraham, H. A., Nachtigal, M. W., Uilenbroek, J. T. J., Grootegoed, J. A., & Themmen, A. P. N. (2002) · Endocrinology · doi:10.1210/en.143.3.1076 · Cited by 843
Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary
Durlinger, A. L. L., Gruijters, M. J. G., Kramer, P., Karels, B., Kumar, T. R., Matzuk, M. M., Rose, U. M., de Jong, F. H., Uilenbroek, J. T. J., Grootegoed, J. A., et al. (2001) · Endocrinology · doi:10.1210/en.142.11.4891 · Cited by 772
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review
Delvigne, A. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.6.559 · Cited by 717
Factors that affect outcome of in-vitro fertilisation treatment
Templeton, A., Morris, J. K., & Parslow, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05291-9 · Cited by 708
Fanchin, R. (2003) · Human Reproduction · doi:10.1093/humrep/deg042 · Cited by 624
Cited by
The physiology and clinical utility of anti-Müllerian hormone in women
Dewailly, D., Andersen, C. Y., Balen, A., Broekmans, F., Dilaver, N., Fanchin, R., Griesinger, G., Kelsey, T. W., La Marca, A., Lambalk, C., et al. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt062 · Cited by 1,049
Self-citationAnti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)
La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A. C., Stabile, G., & Volpe, A. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp036 · Cited by 956
De Vos, M., Devroey, P., & Fauser, B. C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60355-8 · Cited by 763
La Marca, A., & Sunkara, S. K. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt037 · Cited by 586
Broer, S. L., Dolleman, M., Opmeer, B. C., Fauser, B. C., Mol, B. W., & Broekmans, F. J. M. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq034 · Cited by 485
Broer, S. L., van Disseldorp, J., Broeze, K. A., Dolleman, M., Opmeer, B. C., Bossuyt, P., Eijkemans, M. J. C., Mol, B.-W. J., Broekmans, F. J. M., on behalf of the IMPORT study group, et al. (2013) · Human Reproduction Update · doi:10.1093/humupd/dms041 · Cited by 457
Self-citationLambalk, C. B., Banga, F. R., Huirne, J. A., Toftager, M., Pinborg, A., Homburg, R., van der Veen, F., & van Wely, M. (2017) · Human Reproduction Update · doi:10.1093/humupd/dmx017 · Cited by 404
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Nelson, S. M., Yates, R. W., Lyall, H., Jamieson, M., Traynor, I., Gaudoin, M., Mitchell, P., Ambrose, P., & Fleming, R. (2008) · Human Reproduction · doi:10.1093/humrep/den480 · Cited by 339
Self-citationAnti-Mullerian hormone (AMH): what do we still need to know?
La Marca, A., Broekmans, F. J., Volpe, A., Fauser, B. C., Macklon, N. S., & on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology - AMH Round Table (2009) · Human Reproduction · doi:10.1093/humrep/dep210 · Cited by 327
Assessing ovarian response: antral follicle count versus anti-Müllerian hormone
Fleming, R., Seifer, D. B., Frattarelli, J. L., & Ruman, J. (2015) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2015.06.015 · Cited by 291
Self-citationNardo, L. G., Gelbaya, T. A., Wilkinson, H., Roberts, S. A., Yates, A., Pemberton, P., & Laing, I. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.08.127 · Cited by 266
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency
Visser, J. A., Schipper, I., Laven, J. S. E., & Themmen, A. P. N. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.224 · Cited by 264
Iliodromiti, S., Anderson, R. A., & Nelson, S. M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu062 · Cited by 260
Self-citationCumulative live birth rates after ivf in patients with polycystic ovaries: Phenotype matters
De Vos, M., Pareyn, S., Drakopoulos, P., Raimundo, J. M., Anckaert, E., Santos-Ribeiro, S., Polyzos, N. P., Tournaye, H., & Blockeel, C. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.05.003 · Cited by 70
Falorni, A., Brozzetti, A., Aglietti, M. C., Esposito, R., Minarelli, V., Morelli, S., Sbroma Tomaro, E., & Marzotti, S. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04387.x · Cited by 25
Metadata
- Authors
- Nelson, S. M., Yates, R. W., & Fleming, R.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-06-28
- Volume
- 22
- Issue
- 9
- Pages
- 2414-2421
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2137497858
- Cited by
- 391
- References
- 44
- FWCI
- 18.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.